Walgreens Boots Alliance, Inc. logo
Walgreens Boots Alliance, Inc. (WBA)
Compare

WBA Dividends

Walgreens Boots Alliance, Inc. (WBA) pays $1.00 in dividends per share, with a current dividend yield of N/A.

WBA Dividend Summary

Consecutive Years

0

Most Recent Ex-Date

Nov 18, 2024

Most Recent Payment

Dec 12, 2024

WBA Dividends per Share (Nominal History)

View full nominal table list

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.

WBA Dividends CAGR Chart

Walgreens Boots Alliance, Inc. (WBA)

Annual Dividend History

YearDividend/ShareYoY Growth
2024$1.00-47.92%
2023$1.92+0.26%
2022$1.92+1.32%
2021$1.89+2.16%
2020$1.85+3.06%
2019$1.79+6.85%
2018$1.68+8.39%
2017$1.55+5.44%
2016$1.47+5.38%
2015$1.40+6.90%
2014$1.31+10.59%
2013$1.18+18.00%
2012$1.00+25.00%
2011$0.80+28.00%
2010$0.63+25.00%
2009$0.50+20.48%
2008$0.41+20.29%
2007$0.34+21.05%
2006$0.29+21.28%
2005$0.23+22.88%

Quarterly Dividend History

QuarterDividend/ShareYoY Growth
Q4 2024$0.25-47.92%
Q3 2024$0.25-47.92%
Q2 2024$0.25-47.92%
Q1 2024$0.25-47.92%
Q4 2023$0.48+0.00%
Q3 2023$0.48+0.00%
Q2 2023$0.48+0.52%
Q1 2023$0.48+0.52%
Q4 2022$0.48+0.52%
Q3 2022$0.48+0.52%
Q2 2022$0.48+2.14%
Q1 2022$0.48+2.14%
Q4 2021$0.48+2.14%
Q3 2021$0.48+2.14%
Q2 2021$0.47+2.19%
Q1 2021$0.47+2.19%
Q4 2020$0.47+2.19%
Q3 2020$0.47+2.19%
Q2 2020$0.46+3.98%
Q1 2020$0.46+3.98%
Q4 2019$0.46+3.98%
Q3 2019$0.46+3.98%
Q2 2019$0.44+10.00%
Q1 2019$0.44+10.00%

Dividend Yield Metrics

Current Yield
N/A
Average Yield (TTM)
N/A
Average Yield (3Y)
13.45%
Forward Yield on Cost (3Y)
< 3Y history
Forward Yield on Cost (5Y)
< 5Y history
Forward Yield on Cost (10Y)
< 10Y history

Payout Ratio Analysis

Payout Ratio (Current)
N/A
FCF Payout Ratio
N/A
Payout Ratio (3Y Avg)
158.58%
Payout Ratio (5Y Avg)
110.45%
FCF Payout (3Y Avg)
430.34%
FCF Payout (5Y Avg)
274.62%

An FCF payout above 100% means dividends exceeded the period's free cash flow, often because of temporarily depressed FCF (one-off capex or working-capital swings) rather than an unfunded dividend. Compare against the earnings payout ratio and the multi-year trend before drawing a conclusion.

Dividend Coverage

Payout Ratio
N/A
Dividends / net income
FCF Payout Ratio
N/A
Dividends / free cash flow
Consecutive Years
N/A
Years with regular dividend payments
5Y Dividend Growth
-11.0%
Compound annual dividend growth

About Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.

Deerfield, IL
193,000 employees
Healthcare / Medical - Pharmaceuticals
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Timothy C. Wentworth